<VariationArchive VariationID="1457685" VariationName="NC_000011.9:g.(?_66618135)_(66639640_?)del" VariationType="Deletion" Accession="VCV001457685" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1393625" VariationID="1457685">
      <GeneList>
        <Gene Symbol="LRFN4" FullName="leucine rich repeat and fibronectin type III domain containing 4" GeneID="78999" HGNC_ID="HGNC:28456" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="66857064" stop="66860475" display_start="66857064" display_stop="66860475" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="66624875" stop="66627945" display_start="66624875" display_stop="66627945" Strand="+" />
          </Location>
          <OMIM>612810</OMIM>
        </Gene>
        <Gene Symbol="PC" FullName="pyruvate carboxylase" GeneID="5091" HGNC_ID="HGNC:8636" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="66848420" stop="66958383" display_start="66848420" display_stop="66958383" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="66615996" stop="66725846" display_start="66615996" display_stop="66725846" Strand="-" />
          </Location>
          <OMIM>608786</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000011.9:g.(?_66618135)_(66639640_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" innerStart="66618135" innerStop="66639640" display_start="66618135" display_stop="66639640" variantLength="21506" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.(?_66618135)_(66639640_?)del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.(?_66618135)_(66639640_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.9:g.(?_66618135)_(66639640_?)del AND Pyruvate carboxylase deficiency" Accession="RCV001953889" Version="4">
        <ClassifiedConditionList TraitSetID="532">
          <ClassifiedCondition DB="MedGen" ID="C0034341">Pyruvate carboxylase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-04-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12112657</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19306334</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="532" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5842" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pyruvate carboxylase deficiency</ElementValue>
                <XRef ID="Pyruvate+carboxylase+deficiency/6120" DB="Genetic Alliance" />
                <XRef ID="87694001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PC deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia with lactic acidosis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leigh necrotizing encephalopathy due to pyruvate carboxylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leigh syndrome due to pyruvate carboxylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATAXIA WITH LACTIC ACIDOSIS II</ElementValue>
                <XRef Type="MIM" ID="266150" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pyruvate Carboxylase Deficiency Disease</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Pyruvate carboxylase (PC) deficiency is characterized in most affected individuals by failure to thrive, developmental delay, recurrent seizures, and metabolic acidosis. Three clinical types are recognized: Type A (infantile form), in which most affected children die in infancy or early childhood. Type B (severe neonatal form), in which affected infants have hepatomegaly, pyramidal tract signs, and abnormal movement and die within the first three months of life. Type C (intermittent/benign form), in which affected individuals have normal or mildly delayed neurologic development and episodic metabolic acidosis.</Attribute>
                <XRef ID="NBK6852" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7512" />
                <XRef ID="7512" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301764</ID>
                <ID Source="BookShelf">NBK6852</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, ACT Sheet, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrullinemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, [Elevated Citrulline], Amino Acidemia/Urea Cycle Disorder, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrulline-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Elevated Citrulline: Amino Acidemia Algorithm, 2022</CitationText>
              </Citation>
              <XRef ID="3008" DB="Orphanet" />
              <XRef ID="C0034341" DB="MedGen" />
              <XRef ID="MONDO:0009949" DB="MONDO" />
              <XRef Type="MIM" ID="266150" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4257373" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_000920.3_11_Deletion (exons 3-17)|MedGen:C0034341" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002240660" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12112657</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19306334</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with PC-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 3-17 of the PC gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 17 of the PC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PC are known to be pathogenic (PMID: 12112657, 19306334).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.(?_66618135)_(66639640_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0034341" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4257373" TraitType="Disease" MappingType="XRef" MappingValue="C0034341" MappingRef="MedGen">
        <MedGen CUI="C0034341" Name="Pyruvate carboxylase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

